Radiotherapy	B:C1522449
:	O
Changing	O
the	O
Game	O
in	O
Immunotherapy	O
Immune	O
checkpoint	O
inhibitors	I:C1254351
are	O
effective	O
in	O
cancer	O
treatment	I:C0920425
.	O

Radiotherapy	O
:	O
Changing	O
the	O
Game	O
in	O
Immunotherapy	B:C0021083
Immune	O
checkpoint	O
inhibitors	I:C1254351
are	O
effective	O
in	O
cancer	O
treatment	I:C0920425
.	O

Radiotherapy	O
:	O
Changing	O
the	O
Game	O
in	O
Immunotherapy	O
Immune	B:C0020962
checkpoint	O
inhibitors	I:C1254351
are	O
effective	O
in	O
cancer	O
treatment	I:C0920425
.	O

Radiotherapy	O
:	O
Changing	O
the	O
Game	O
in	O
Immunotherapy	O
Immune	O
checkpoint	B:C1254351
inhibitors	I:C1254351
are	O
effective	O
in	O
cancer	O
treatment	I:C0920425
.	O

Radiotherapy	O
:	O
Changing	O
the	O
Game	O
in	O
Immunotherapy	O
Immune	O
checkpoint	O
inhibitors	I:C1254351
are	O
effective	O
in	O
cancer	B:C0920425
treatment	I:C0920425
.	O

A	O
pre-existing	O
immune	B:C0301872
response	I:C0301872
demonstrated	O
by	O
significant	O
pretreatment	O
tumor	O
lymphocytic	I:C1262091
infiltration	I:C1262091
is	O
a	O
pre-requisite	O
for	O
response	O
.	O

A	O
pre-existing	O
immune	O
response	I:C0301872
demonstrated	O
by	O
significant	O
pretreatment	O
tumor	B:C1262091
lymphocytic	I:C1262091
infiltration	I:C1262091
is	O
a	O
pre-requisite	O
for	O
response	O
.	O

A	O
pre-existing	O
immune	O
response	I:C0301872
demonstrated	O
by	O
significant	O
pretreatment	O
tumor	O
lymphocytic	I:C1262091
infiltration	I:C1262091
is	O
a	O
pre-requisite	O
for	O
response	B:C0301872
.	O

Within	O
such	O
infiltrated	B:C0677898
tumors	I:C0677898
,	O
referred	O
as	O
"	O
hot	O
"	O
,	O
immune	O
checkpoint	O
inhibitors	I:C1254351
rescue	O
anti-tumor	O
T	O
cells	I:C1152851
activity	I:C1152851
.	O

Within	O
such	O
infiltrated	O
tumors	I:C0677898
,	O
referred	O
as	O
"	O
hot	O
"	O
,	O
immune	B:C0020962
checkpoint	O
inhibitors	I:C1254351
rescue	O
anti-tumor	O
T	O
cells	I:C1152851
activity	I:C1152851
.	O

Within	O
such	O
infiltrated	O
tumors	I:C0677898
,	O
referred	O
as	O
"	O
hot	O
"	O
,	O
immune	O
checkpoint	B:C1254351
inhibitors	I:C1254351
rescue	O
anti-tumor	O
T	O
cells	I:C1152851
activity	I:C1152851
.	O

Within	O
such	O
infiltrated	O
tumors	I:C0677898
,	O
referred	O
as	O
"	O
hot	O
"	O
,	O
immune	O
checkpoint	O
inhibitors	I:C1254351
rescue	O
anti-tumor	O
T	B:C1152851
cells	I:C1152851
activity	I:C1152851
.	O

In	O
contrast	O
,	O
"	B:C0027651
cold	I:C0027651
"	I:C0027651
tumors	I:C0027651
lack	O
lymphocytic	O
infiltration	I:C1262091
and	O
are	O
refractory	O
to	O
immunotherapy	O
.	O

In	O
contrast	O
,	O
"	O
cold	I:C0027651
"	I:C0027651
tumors	I:C0027651
lack	O
lymphocytic	B:C1262091
infiltration	I:C1262091
and	O
are	O
refractory	O
to	O
immunotherapy	O
.	O

In	O
contrast	O
,	O
"	O
cold	I:C0027651
"	I:C0027651
tumors	I:C0027651
lack	O
lymphocytic	O
infiltration	I:C1262091
and	O
are	O
refractory	O
to	O
immunotherapy	B:C0021083
.	O

Preclinical	B:C1516606
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	O
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	B:C1522449
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	O
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	B:C1335729
tumors	I:C1335729
to	O
immune	O
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	B:C0020962
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	O
checkpoint	B:C1254351
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	O
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	B:C0003392
T	O
cells	I:C0039194
.	O

Preclinical	O
data	I:C1516606
show	O
that	O
radiotherapy	O
sensitizes	O
refractory	O
tumors	I:C1335729
to	O
immune	O
checkpoint	O
inhibitors	I:C1254351
by	O
recruiting	O
anti-tumor	O
T	B:C0039194
cells	I:C0039194
.	O

Despite	O
the	O
growing	O
number	O
of	O
clinical	B:C0008972
studies	I:C0008972
testing	O
radiation	O
's	O
ability	O
to	O
enhance	O
immunotherapy	O
,	O
clinical	O
evidence	O
that	O
it	O
converts	O
cold	O
tumors	I:C0027651
into	O
responsive	O
ones	O
remains	O
elusive	O
.	O

Despite	O
the	O
growing	O
number	O
of	O
clinical	O
studies	I:C0008972
testing	O
radiation	O
's	O
ability	O
to	O
enhance	O
immunotherapy	B:C0021083
,	O
clinical	O
evidence	O
that	O
it	O
converts	O
cold	O
tumors	I:C0027651
into	O
responsive	O
ones	O
remains	O
elusive	O
.	O

Despite	O
the	O
growing	O
number	O
of	O
clinical	O
studies	I:C0008972
testing	O
radiation	O
's	O
ability	O
to	O
enhance	O
immunotherapy	O
,	O
clinical	O
evidence	O
that	O
it	O
converts	O
cold	B:C0027651
tumors	I:C0027651
into	O
responsive	O
ones	O
remains	O
elusive	O
.	O

Here	O
we	O
review	O
evidence	O
that	O
radiotherapy	B:C1522449
is	O
not	O
only	O
an	O
occasional	O
enhancer	O
of	O
immunotherapy	O
's	I:C0021083
effects	O
but	O
a	O
"	O
game	O
changer	O
"	O
,	O
and	O
propose	O
a	O
blueprint	O
to	O
test	O
this	O
.	O

Here	O
we	O
review	O
evidence	O
that	O
radiotherapy	O
is	O
not	O
only	O
an	O
occasional	O
enhancer	O
of	O
immunotherapy	B:C0021083
's	I:C0021083
effects	O
but	O
a	O
"	O
game	O
changer	O
"	O
,	O
and	O
propose	O
a	O
blueprint	O
to	O
test	O
this	O
.	O

